Profiling the evolution of human metastatic bladder cancer.
about
Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancerSrc phosphorylation of RhoGDI2 regulates its metastasis suppressor function.Tumour exosomes display differential mechanical and complement activation properties dependent on malignant state: implications in endothelial leakinessOverlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration.Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer.The Ral GTPase pathway in metastatic bladder cancer: key mediator and therapeutic targetTranslation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonizationCD24 is an effector of HIF-1-driven primary tumor growth and metastasis.A gene expression ratio-based diagnostic test for bladder cancerRalBP1 is necessary for metastasis of human cancer cell linesGenoproteomic mining of urothelial cancer suggests {gamma}-glutamyl hydrolase and diazepam-binding inhibitor as putative urinary markers of outcome after chemotherapy.Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination.A novel method for gene expression mapping of metastatic competence in human bladder cancerComparative analysis of metastasis variants derived from human prostate carcinoma cells: roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasionComparative analysis of discrete exosome fractions obtained by differential centrifugation.The transcripts of SFRP1,CEP63 and EIF4G2 genes are frequently downregulated in transitional cell carcinomas of the bladder.A systems biology analysis of metastatic melanoma using in-depth three-dimensional protein profiling.High epiregulin expression in human U87 glioma cells relies on IRE1α and promotes autocrine growth through EGF receptor.Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.Putative multifunctional signature of lung metastases in dedifferentiated chondrosarcoma.Functional genomic analysis of cancer metastasis: biologic insights and clinical implications.Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis.Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid SynthesisDevelopment of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancer.Molecular alterations associated with bladder cancer initiation and progression.Autocrine epiregulin activates EGFR pathway for lung metastasis via EMT in salivary adenoid cystic carcinoma.Tumor endothelial cells promote metastasis and cancer stem cell-like phenotype through elevated Epiregulin in esophageal cancer.Epiregulin as a therapeutic target in non-small-cell lung cancerEpiregulin: roles in normal physiology and cancerThe cytotoxic activities of 7-isopentenyloxycoumarin on 5637 cells via induction of apoptosis and cell cycle arrest in G2/M stage.Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.An Osteopontin/CD44 Axis in RhoGDI2-Mediated Metastasis SuppressionRapid fatal outcome from pulmonary arteries compression in transitional cell carcinoma.Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines.
P2860
Q24623746-F705EEFF-D168-4BC8-B1AB-8288A9BA321AQ24645336-7CE4199C-A42D-4478-947D-30CA9B217203Q27303307-14CDEF84-0F3E-4650-912B-9B08EFFD63AEQ28291731-758E7EF0-B9F1-456E-81E8-F9ACF2C2CCF7Q30408466-1F6ECDDB-8453-4FAA-B4A5-DAF78CC7CAD6Q30415154-0163AA97-4CEC-4244-9103-7557B60EB18AQ30416020-F21A12FD-8B05-4618-A051-F2866CD0A7B0Q30416514-032E6C06-EF29-412C-AB27-C65A5F5AD188Q30430715-A631BADC-A61C-448A-A9CB-8311CE2AE846Q30433862-31221EB4-EE19-42A6-AF39-9DFCE486D19FQ30434237-B5A2698B-0F5A-4E0E-8EA6-B208369944F1Q30439008-C29558D9-DB16-41C2-994D-6F5356F9BC1AQ30440217-9A1EFDB2-F88C-4893-AA34-91284F760339Q30490521-55727D75-0AEE-40BF-AC57-240580B7290CQ34474459-A03473FE-BE52-42D1-829A-05A2C181882BQ34484329-38B754E5-2C79-49F4-8DF7-79628B436E3DQ34762291-360B22B4-AD78-45E0-A264-0B7E394A3816Q35065342-6EE5DF94-6D16-4781-9322-785BB9FFC688Q35671281-3E404E92-20BB-4FD1-B37C-EBBCF8B95928Q35789112-0AD55A12-95C2-4053-A6C6-38727E049741Q36150368-8D30AB1F-9E22-41FF-B4A9-78D00B5B14A6Q36341182-E975DA72-ACB0-4469-806F-1999BD9073F5Q36593641-6F27352B-1E64-4231-BDA4-463B3DC490A9Q36642643-3B0AA81A-773F-4D29-B6F7-A7907367DBD9Q37269864-C5A18AD3-F673-46B2-91C3-7BF18D087C0DQ37279001-8735CE51-9F12-4642-B920-582BAD7FA3AFQ37295302-3DCE1EB7-DF36-4CAA-A6E6-F7CEA7FE4DF9Q37382532-49C18581-CD98-438F-BD2C-B23C6E95460CQ37566850-C4191CE6-E73D-4123-9924-A3D730558BC5Q38196137-D71351DF-3ACB-4128-8AAC-21EE2782BA9DQ39037071-9AFC847D-7805-4D4B-BDCF-548BC561AF68Q39038597-30234966-1825-4360-B239-37229EB84499Q39424176-1C1CFE11-0F3A-47AB-B179-3F7EB204E6C2Q41809067-7C787498-4A2D-40BD-946B-000105367BF4Q46349394-FFCCEBD7-74C3-4F7B-9A45-EE955B7F182EQ55397522-78EF74E3-82D0-4AB0-9FDF-C127D5CA9AFB
P2860
Profiling the evolution of human metastatic bladder cancer.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Profiling the evolution of human metastatic bladder cancer.
@ast
Profiling the evolution of human metastatic bladder cancer.
@en
type
label
Profiling the evolution of human metastatic bladder cancer.
@ast
Profiling the evolution of human metastatic bladder cancer.
@en
prefLabel
Profiling the evolution of human metastatic bladder cancer.
@ast
Profiling the evolution of human metastatic bladder cancer.
@en
P2093
P4510
P1433
P1476
Profiling the evolution of human metastatic bladder cancer.
@en
P2093
Brian E Nicholson
Dan Theodorescu
Garret M Hampton
Henry F Frierson
Jabed M Seraj
Mark R Conaway
P304
P356
10.1158/0008-5472.CAN-04-0826
P407
P577
2004-11-01T00:00:00Z